[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - The drug advocated by President Jair Bolsonaro to fight the Covid-19 pandemic, despite no scientific proof of its efficacy, has come into the Audit Court's sights. An investigation was requested by the Prosecutor's Office (MP) to establish whether there was overbilling in the purchase of raw materials for the production of chloroquine tablets by Subscribe to our Premium Membership Plan. Already Subscribed?